(Q43670746)

25 November 2017

title

Homocysteine--a treatable risk factor for allograft vascular disease after heart transplantation? (English)

1 reference

25 November 2017

1 reference

Kutschka I

1

1 reference

25 November 2017

Pethig K

2

1 reference

25 November 2017

Strüber M

3

1 reference

25 November 2017

Dieterich C

4

1 reference

25 November 2017

Harringer W

5

1 reference

25 November 2017

Haverich A

6

1 reference

25 November 2017

publication date

1 July 2001

1 reference

The Journal of Heart and Lung Transplantation

25 November 2017

published in

1 reference

25 November 2017

volume

20

1 reference

25 November 2017

issue

7

1 reference

25 November 2017

page(s)

743-746

1 reference

Hyperhomocyst(e)inemia and atherothrombosis

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Increase in total plasma homocysteine concentration after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Association of mild hyperhomocysteinemia with cardiac graft vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900240-6

7 January 2021

10.1016/S1053-2498(01)00240-6

Identifiers

DOI

1 reference

25 November 2017

1 reference